Literature DB >> 2721658

HIV-disease and bone marrow changes: a study of 60 cases.

N Mir1, C Costello, J Luckit, R Lindley.   

Abstract

We report our experience of peripheral blood and bone marrow changes in patients with HIV disease. Abnormalities were most commonly seen in patients with advanced disease. In AIDS group IV patients (CDC classification) anaemia (92%) neutropenia (85%) monocytopenia (75%) and thrombocytopenia (61%) have their highest incidence, the reason being a combination of factors such as infection, myelosuppressive drugs and HIV infection itself. Bone marrow examinations were performed most commonly for microbiological culture (25%) and the investigation of anaemia (16%). Morphological changes in the bone marrow were non-specific and not pathognomic; however erythroid hypoplasia was found to be a distinctive feature associated with MAI infection. The procedure provided a high yield for microbiological culture, particularly in MAI infection.

Entities:  

Mesh:

Year:  1989        PMID: 2721658     DOI: 10.1111/j.1600-0609.1989.tb01222.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  16 in total

1.  HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region.

Authors:  Menghua Zhang; Stella Evans; Jinyun Yuan; Lee Ratner; Prasad S Koka
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

2.  Diagnostic utility of bone marrow sampling in HIV positive patients.

Authors:  M G Brook; H Ayles; C Harrison; C Rowntree; R F Miller
Journal:  Genitourin Med       Date:  1997-04

3.  Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo.

Authors:  P S Koka; B D Jamieson; D G Brooks; J A Zack
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 4.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

5.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?

Authors:  Bruce J Brew; Louise Pemberton; John Ray
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

7.  Aplastic anemia in an HIV infected child.

Authors:  Ira Shah; Anuradha K Murthy
Journal:  Indian J Pediatr       Date:  2005-04       Impact factor: 5.319

8.  Profile of hematological abnormalities of Indian HIV infected individuals.

Authors:  Byomakesh Dikshit; Ajay Wanchu; Ravinder Kaur Sachdeva; Aman Sharma; Reena Das
Journal:  BMC Blood Disord       Date:  2009-08-13

9.  FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.

Authors:  Sheng-Kai Liang; Chia-Chan Hsu; Hsiang-Lin Song; Yu-Chi Huang; Chun-Wei Kuo; Xiang Yao; Chien-Cheng Li; Hui-Chen Yang; Yu-Ling Hung; Sheng-Yang Chao; Shun-Chi Wu; Feng-Ren Tsai; Jen-Kun Chen; Wei-Neng Liao; Shih-Chin Cheng; Tsui-Chun Tsou; I-Ching Wang
Journal:  Oncogene       Date:  2021-06-21       Impact factor: 9.867

10.  Comparison of Adenosine Deaminase, Zinc, Magnesium, Lipid Profile, and some Micronutrient Elements and their Relation with CD4 Counts in Human Immunodeficiency Virus Positive and Negative Patients.

Authors:  Alireza Abdollahi; Saeed Shoar
Journal:  J Glob Infect Dis       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.